IPHA · Innate Pharma SA · Financials
Market Cap
$208.88M
Shares
111.70M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
9.01M
-55.2%
FY2025
Net Income
-49.18M
+0.6%
FY2025
Operating Margin
-599.76%
-343.4pp
FY2025
Diluted EPS
-0.55
+9.8%
FY2025
Operating Cash Flow
-52.76M
-665%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| EUR | 9.01M | 20.12M | 61.64M | 57.67M | 24.7M | 69.77M | 85.45M | 93.95M | 44.03M |
| EUR | 43.62M | 51.98M | 56.02M | 51.66M | 47M | 49.71M | 62.9M | 69.56M | 67M |
| EUR | 519K | 353K | 368K | 660K | 472K | 504K | 592K | 518K | 649K |
| EUR | 19.39M | 19.72M | 18.29M | — | — | — | — | 18.14M | — |
| EUR | 1.38M | 1.99M | 5.09M | 4.42M | 4.57M | 9.39M | 13.74M | 7.4M | 4.4M |
| EUR | -54.01M | -51.58M | -12.67M | -57.43M | -47.83M | 1.08M | 1.58M | 5.15M | -39.98M |
| EUR | 3.12M | 3.98M | 1.84M | 5.32M | 4M | 6.76M | 4.98M | 8.43M | 10.54M |
| EUR | -49.18M | -49.47M | -7.57M | -57.97M | -45.48M | -829K | 7.87M | 2.72M | -48.02M |
| EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -333K | 368K |
| EUR | -49.18M | -49.47M | -7.57M | -58.1M | -52.81M | -63.98M | -20.76M | 3.05M | -48.39M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.